Fulcrum Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 02/17/2026 | 6.56 M | $74.21 M | 21.93% | 10.48% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 6.05 M | $68.47 M | -40.82% | 9.67% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 5.25 M | $59.38 M | 0.00% | 8.39% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 4.29 M | $48.56 M | -8.08% | 6.86% |
| BLACKROCK, INC. | 02/12/2026 | 4.26 M | $48.22 M | 15.03% | 6.81% |
| VANGUARD GROUP INC | 01/29/2026 | 3.56 M | $40.26 M | 18.67% | 5.69% |
| BRAIDWELL LP | 02/17/2026 | 3.06 M | $34.62 M | 1,294.71% | 4.89% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.40 M | $27.12 M | 100.00% | 3.83% |
| SIREN, L.L.C. | 02/13/2026 | 1.95 M | $22.05 M | 100.00% | 3.12% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.91 M | $21.64 M | 32.04% | 3.06% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 1.89 M | $21.41 M | 100.00% | 3.02% |
| GSK PLC | 02/12/2026 | 1.79 M | $20.20 M | 100.00% | 2.85% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.70 M | $19.23 M | -30.10% | 2.72% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 1.38 M | $15.56 M | 6.69% | 2.20% |
| ABRDN PLC | 01/16/2026 | 1.25 M | $14.18 M | 808.97% | 2.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 1.25 M | $14.18 M | 267.01% | 2.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.21 M | $13.65 M | 41.24% | 1.93% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.11 M | $12.51 M | 10.14% | 1.77% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.05 M | $11.89 M | -19.10% | 1.68% |
| STATE STREET CORP | 02/13/2026 | 1.01 M | $11.37 M | -5.44% | 1.61% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 970.44 K | $10.98 M | -33.10% | 1.55% |
| VESTAL POINT CAPITAL, LP | 02/17/2026 | 950.00 K | $10.74 M | 100.00% | 1.52% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 800.00 K | $9.05 M | 100.00% | 1.28% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 736.74 K | $8.33 M | 36.27% | 1.18% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 582.38 K | $6.59 M | 51.61% | 0.93% |
| NORTHERN TRUST CORP | 02/17/2026 | 552.22 K | $6.25 M | -2.83% | 0.88% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 517.53 K | $5.85 M | -23.72% | 0.83% |
| JANE STREET GROUP, LLC | 02/12/2026 | 493.75 K | $5.58 M | 53.57% | 0.79% |
| INVESCO LTD. | 02/19/2026 | 417.19 K | $4.72 M | 236.79% | 0.67% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 394.65 K | $4.46 M | 100.00% | 0.63% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 392.49 K | $4.44 M | 100.00% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 388.90 K | $4.40 M | 16.62% | 0.62% |
| SIO CAPITAL MANAGEMENT, LLC | 02/17/2026 | 382.00 K | $4.32 M | 100.00% | 0.61% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 355.55 K | $4.02 M | 1,591.87% | 0.57% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 323.88 K | $3.66 M | -44.76% | 0.52% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 287.10 K | $3.25 M | 0.62% | 0.46% |
| BESSEMER GROUP INC | 02/05/2026 | 286.99 K | $3.25 M | 0.00% | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 243.39 K | $2.75 M | 100.00% | 0.39% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 231.18 K | $2.61 M | 57.04% | 0.37% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 201.30 K | $2.28 M | 100.00% | 0.32% |
| NICHOLAS INVESTMENT PARTNERS, LP | 02/13/2026 | 182.96 K | $2.07 M | 100.00% | 0.29% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 166.40 K | $1.88 M | 411.87% | 0.27% |
| MORGAN STANLEY | 02/13/2026 | 165.62 K | $1.87 M | -32.08% | 0.26% |
| SIMPLIFY ASSET MANAGEMENT INC. | 02/09/2026 | 159.67 K | $1.81 M | 91.84% | 0.26% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 157.67 K | $1.78 M | 3.57% | 0.25% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 146.43 K | $1.66 M | -18.36% | 0.23% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 140.50 K | $1.59 M | 111.28% | 0.22% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 138.14 K | $1.56 M | 100.00% | 0.22% |
| FIDUCIARY TRUST CO | 02/13/2026 | 136.56 K | $1.54 M | 0.00% | 0.22% |
| BARCLAYS PLC | 02/13/2026 | 132.54 K | $1.50 M | 47.90% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fulcrum Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 215 institutional investors and hedge funds held shares of Fulcrum Therapeutics Inc. The most heavily invested institutionals were:
abrdn plc: 2.21 M
Assenagon Asset Management S.A.: 1.19 M
DIMENSIONAL FUND ADVISORS LP: 1.13 M
Connor, Clark & Lunn Investment Management Ltd.: 736,684
VANGUARD FIDUCIARY TRUST CO: 329,884
UBS Group AG: 315,185
107.74% of Fulcrum Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 75.10 M shares in the last 24 months. This purchase volume represents approximately $596.31 M in transactions.